Healthcare Sector Stocks
The Healthcare sector has a total of 1062 stocks, with a combined market cap of $8.35 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.53.
Market Cap
8.35T
Revenue
4.52T
Profits
201B
PE Ratio
41.53
Profit Margin
4.45%
Dividend Yield
0.43%
1062 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 808.91B | -0.11% | 2,836,575 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 564.92B | -1.73% | 8,668,883 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 369.65B | 0.27% | 5,075,395 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 311.85B | -0.37% | 1,414,402 | 58.74B |
| 5 | UNH | UnitedHealth Group Incorporated | 287.19B | 0.75% | 5,205,638 | 447.57B |
| 6 | NVS | Novartis AG | 285.76B | -1.55% | 1,066,063 | 56.67B |
| 7 | MRK | Merck & Co., Inc. | 285.17B | -2.07% | 11,399,887 | 65.01B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 191.76B | -2.95% | 1,375,322 | 44.56B |
| 9 | AMGN | Amgen Inc. | 188.56B | 0.34% | 1,981,741 | 36.75B |
| 10 | NVO | Novo Nordisk A/S | 179.79B | 0.29% | 16,083,753 | 48.59B |
| 11 | GILD | Gilead Sciences, Inc. | 171.97B | -0.87% | 3,432,531 | 29.44B |
| 12 | ABT | Abbott Laboratories | 166.28B | -6.00% | 27,791,161 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 162.70B | -2.19% | 2,209,623 | 10.06B |
| 14 | PFE | Pfizer Inc. | 154.84B | 0.11% | 21,905,298 | 62.58B |
| 15 | DHR | Danaher Corporation | 137.14B | -2.20% | 3,760,486 | 24.57B |
| 16 | SYK | Stryker Corporation | 129.59B | -0.84% | 1,609,787 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.38B | 1.85% | 8,220,670 | 48.19B |
| 18 | SNY | Sanofi | 114.97B | -0.62% | 2,173,704 | 54.85B |
| 19 | GSK | GSK plc | 114.74B | -1.18% | 3,002,824 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 110.81B | -1.37% | 1,364,285 | 12.00B |
| 21 | MDT | Medtronic plc | 109.96B | -1.66% | 8,816,851 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 107.98B | -1.15% | 821,532 | 75.60B |
| 23 | MCK | McKesson Corporation | 106.24B | 0.45% | 520,746 | 397.96B |
| 24 | CVS | CVS Health Corporation | 98.41B | 2.40% | 10,594,716 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 94.25B | -1.84% | 10,656,921 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.55B | -1.05% | 505,374 | 14.34B |
| 27 | CI | The Cigna Group | 72.87B | 2.88% | 1,270,731 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 69.37B | 1.49% | 1,350,044 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.71B | 1.51% | 1,233,656 | 325.78B |
| 30 | MDLN | Medline Inc. | 61.66B | -2.07% | 5,333,155 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 55.44B | -0.39% | 2,983,645 | 28.48B |
| 32 | ARGX | argenx SE | 52.04B | -1.49% | 255,485 | 4.24B |
| 33 | CAH | Cardinal Health, Inc. | 50.15B | 0.60% | 1,163,724 | 244.67B |
| 34 | ZTS | Zoetis Inc. | 50.06B | -1.42% | 2,989,437 | 9.47B |
| 35 | EW | Edwards Lifesciences Corporation | 45.58B | 1.09% | 6,192,792 | 6.07B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.27B | -1.86% | 337,655 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.08B | -0.45% | 4,071,484 | 21.92B |
| 38 | HLN | Haleon plc | 42.51B | -0.72% | 5,057,911 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.46B | -3.98% | 1,022,842 | 3.71B |
| 40 | ALC | Alcon Inc. | 39.12B | -1.46% | 985,923 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.40B | -1.11% | 4,682,233 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 35.57B | 0.24% | 206,871 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 33.42B | -1.27% | 1,697,848 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.40B | -0.42% | 2,685,891 | 20.63B |
| 45 | RMD | ResMed Inc. | 32.59B | -1.78% | 1,093,543 | 5.40B |
| 46 | WAT | Waters Corporation | 31.32B | -2.19% | 733,531 | 3.17B |
| 47 | RVMD | Revolution Medicines, Inc. | 31.16B | -2.14% | 5,701,860 | - |
| 48 | INSM | Insmed Incorporated | 30.82B | -2.69% | 2,160,901 | 606.42M |
| 49 | IQV | IQVIA Holdings Inc. | 28.86B | -3.45% | 1,536,819 | 16.31B |
| 50 | RPRX | Royalty Pharma plc | 27.97B | -0.45% | 2,107,813 | 2.38B |
| 51 | NTRA | Natera, Inc. | 27.79B | -5.35% | 1,849,024 | 2.31B |
| 52 | PHG | Koninklijke Philips N.V. | 27.65B | -1.58% | 1,577,728 | 20.94B |
| 53 | VEEV | Veeva Systems Inc. | 27.39B | 0.23% | 2,298,200 | 3.20B |
| 54 | MTD | Mettler-Toledo International Inc. | 26.14B | -1.90% | 168,632 | 4.03B |
| 55 | BIIB | Biogen Inc. | 25.83B | -2.50% | 953,723 | 9.89B |
| 56 | BNTX | BioNTech SE | 25.82B | 2.66% | 647,120 | 3.37B |
| 57 | UTHR | United Therapeutics Corporation | 25.44B | 0.51% | 474,744 | 3.18B |
| 58 | HUM | Humana Inc. | 24.10B | 1.20% | 1,825,500 | 129.66B |
| 59 | DXCM | DexCom, Inc. | 23.63B | -0.50% | 5,747,291 | 4.66B |
| 60 | LH | Labcorp Holdings Inc. | 21.89B | -0.14% | 592,840 | 13.95B |
| 61 | MRNA | Moderna, Inc. | 21.69B | 0.77% | 5,092,571 | 1.94B |
| 62 | STE | STERIS plc | 21.57B | -0.69% | 832,199 | 5.83B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.19B | 0.02% | 987,367 | 11.04B |
| 64 | ROIV | Roivant Sciences Ltd. | 20.89B | -0.68% | 5,740,302 | 13.31M |
| 65 | ILMN | Illumina, Inc. | 20.16B | 0.35% | 1,325,563 | 4.34B |
| 66 | WST | West Pharmaceutical Services, Inc. | 19.43B | 1.24% | 894,270 | 3.07B |
| 67 | CNC | Centene Corporation | 19.18B | 3.72% | 6,623,844 | 176.15B |
| 68 | INCY | Incyte Corporation | 18.97B | -1.83% | 1,616,847 | 5.14B |
| 69 | SMMT | Summit Therapeutics Inc. | 18.93B | 15.63% | 6,793,286 | - |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 18.35B | 0.62% | 1,362,529 | 8.23B |
| 71 | GMAB | Genmab A/S | 17.31B | -3.41% | 1,240,257 | 3.72B |
| 72 | THC | Tenet Healthcare Corporation | 16.70B | -0.81% | 719,876 | 21.31B |
| 73 | VTRS | Viatris Inc. | 16.31B | 1.08% | 9,422,503 | 14.30B |
| 74 | RGC | Regencell Bioscience Holdings Limited | 15.12B | 2.55% | 55,394 | - |
| 75 | BBIO | BridgeBio Pharma, Inc. | 15.03B | -0.24% | 917,778 | 502.08M |
| 76 | ASND | Ascendis Pharma A/S | 15.01B | 0.51% | 559,895 | 845.52M |
| 77 | MEDP | Medpace Holdings, Inc. | 14.73B | -0.56% | 345,112 | 2.53B |
| 78 | SNN | Smith & Nephew plc | 14.46B | -1.14% | 664,016 | 6.16B |
| 79 | PODD | Insulet Corporation | 13.95B | -0.51% | 744,797 | 2.71B |
| 80 | COO | The Cooper Companies, Inc. | 13.54B | -1.29% | 2,141,892 | 4.15B |
| 81 | ALGN | Align Technology, Inc. | 13.25B | -0.81% | 645,913 | 4.03B |
| 82 | PEN | Penumbra, Inc. | 13.03B | -0.29% | 256,144 | 1.40B |
| 83 | NBIX | Neurocrine Biosciences, Inc. | 12.89B | -2.31% | 1,030,448 | 2.86B |
| 84 | GMED | Globus Medical, Inc. | 12.55B | -1.89% | 902,584 | 2.94B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.43B | -2.03% | 1,873,900 | 943.71M |
| 86 | FMS | Fresenius Medical Care AG | 12.37B | -0.31% | 1,090,979 | 23.05B |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 12.18B | -0.75% | 2,303,305 | 4.27B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.04B | 1.19% | 198,217 | 958.40M |
| 89 | SOLV | Solventum Corporation | 11.94B | -0.32% | 1,314,200 | 8.33B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.55B | -0.43% | 4,061,141 | 4.72B |
| 91 | ENSG | The Ensign Group, Inc. | 11.55B | -0.10% | 158,900 | 5.06B |
| 92 | EXEL | Exelixis, Inc. | 11.53B | 0.23% | 2,069,848 | 2.32B |
| 93 | GH | Guardant Health, Inc. | 11.24B | 0.99% | 1,984,246 | 982.02M |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 10.93B | 0.93% | 1,701,513 | 3.85B |
| 95 | UHS | Universal Health Services, Inc. | 10.91B | -0.79% | 497,486 | 17.36B |
| 96 | EHC | Encompass Health Corporation | 10.49B | 0.24% | 772,624 | 5.94B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.40B | -2.12% | 1,459,410 | 3.22B |
| 98 | RVTY | Revvity, Inc. | 10.01B | -3.63% | 1,192,219 | 2.86B |
| 99 | DVA | DaVita Inc. | 9.89B | 2.46% | 779,518 | 13.64B |
| 100 | TEM | Tempus AI, Inc. | 9.75B | -3.53% | 8,756,645 | 1.27B |
| 101 | ABVX | ABIVAX Société Anonyme | 9.62B | 0.81% | 748,645 | 5.37M |
| 102 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.52B | -4.19% | 1,952,892 | 1.09B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 9.42B | 0.01% | 410,135 | 638.50M |
| 104 | BTSG | BrightSpring Health Services, Inc. | 9.38B | -0.46% | 1,314,743 | 12.91B |
| 105 | BAX | Baxter International Inc. | 9.36B | 3.07% | 6,056,904 | 11.24B |
| 106 | MASI | Masimo Corporation | 9.31B | -0.06% | 566,663 | 1.53B |
| 107 | TECH | Bio-Techne Corporation | 8.97B | -1.93% | 2,034,917 | 1.22B |
| 108 | PCVX | Vaxcyte, Inc. | 8.95B | 2.89% | 1,363,830 | - |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 8.92B | -5.75% | 479,050 | 7.46M |
| 110 | HSIC | Henry Schein, Inc. | 8.86B | -0.27% | 908,626 | 13.18B |
| 111 | ICLR | ICON Public Limited Company | 8.83B | -0.79% | 1,139,196 | 8.10B |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.73B | -2.00% | 915,067 | 4.02B |
| 113 | QGEN | Qiagen N.V. | 8.47B | -1.63% | 1,291,255 | 2.09B |
| 114 | ATR | AptarGroup, Inc. | 8.18B | -1.05% | 393,826 | 3.78B |
| 115 | NUVL | Nuvalent, Inc. | 8.17B | -0.85% | 591,160 | - |
| 116 | CYTK | Cytokinetics, Incorporated | 8.06B | 0.08% | 1,168,813 | 88.04M |
| 117 | HALO | Halozyme Therapeutics, Inc. | 7.90B | -2.07% | 1,589,257 | 1.40B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.86B | -1.65% | 286,870 | 2.58B |
| 119 | KRYS | Krystal Biotech, Inc. | 7.77B | -1.67% | 224,689 | 389.13M |
| 120 | MOH | Molina Healthcare, Inc. | 7.75B | 1.41% | 1,017,249 | 43.56B |
| 121 | IBRX | ImmunityBio, Inc. | 7.49B | -6.81% | 17,552,939 | 113.29M |
| 122 | RGEN | Repligen Corporation | 7.17B | -3.67% | 703,414 | 738.26M |
| 123 | HQY | HealthEquity, Inc. | 7.14B | 1.03% | 878,580 | 1.31B |
| 124 | GKOS | Glaukos Corporation | 7.06B | 0.51% | 793,520 | 507.44M |
| 125 | KYMR | Kymera Therapeutics, Inc. | 7.03B | -3.21% | 554,950 | 39.21M |
| 126 | GRFS | Grifols, S.A. | 6.93B | -1.04% | 505,199 | 8.83B |
| 127 | ACLX | Arcellx, Inc. | 6.75B | 0.09% | 434,554 | 22.29M |
| 128 | APGE | Apogee Therapeutics, Inc. | 6.69B | 1.38% | 661,349 | - |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | -1.62% | 417,822 | 46.02M |
| 130 | BLTE | Belite Bio, Inc | 6.22B | -6.35% | 354,501 | - |
| 131 | HIMS | Hims & Hers Health, Inc. | 6.15B | 11.12% | 80,363,681 | 2.35B |
| 132 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.20% | 2,510,812 | 15.00M |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | -0.04% | 4,775,818 | - |
| 134 | CELC | Celcuity Inc. | 6.05B | 1.44% | 1,103,897 | - |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | 0.34% | 763,523 | 189.76M |
| 136 | SYRE | Spyre Therapeutics, Inc. | 5.94B | 1.03% | 2,195,106 | - |
| 137 | PTCT | PTC Therapeutics, Inc. | 5.93B | -2.54% | 1,171,066 | 1.73B |
| 138 | BRKR | Bruker Corporation | 5.93B | -1.37% | 1,512,301 | 3.44B |
| 139 | BLCO | Bausch + Lomb Corporation | 5.88B | -1.72% | 192,652 | 5.10B |
| 140 | COGT | Cogent Biosciences, Inc. | 5.83B | -0.36% | 1,677,121 | - |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 5.78B | -0.56% | 321,547 | 521.31M |
| 142 | CAI | Caris Life Sciences, Inc. | 5.76B | -2.63% | 1,775,682 | 812.03M |
| 143 | TFX | Teleflex Incorporated | 5.76B | 3.07% | 1,549,468 | 1.99B |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.74B | 1.38% | 2,567,058 | - |
| 145 | ERAS | Erasca, Inc. | 5.67B | 0.16% | 2,917,854 | - |
| 146 | ALKS | Alkermes plc | 5.61B | 1.64% | 1,602,012 | 1.48B |
| 147 | CGON | CG Oncology, Inc. | 5.60B | -1.98% | 1,295,309 | 4.04M |
| 148 | AVTR | Avantor, Inc. | 5.58B | -1.31% | 7,865,567 | 6.55B |
| 149 | XENE | Xenon Pharmaceuticals Inc. | 5.58B | -0.76% | 976,876 | 7.50M |
| 150 | IMVT | Immunovant, Inc. | 5.57B | -0.29% | 2,143,313 | - |
| 151 | LNTH | Lantheus Holdings, Inc. | 5.45B | -0.02% | 618,215 | 1.54B |
| 152 | PACS | PACS Group, Inc. | 5.40B | -1.46% | 746,711 | 5.29B |
| 153 | CRSP | CRISPR Therapeutics AG | 5.35B | -1.83% | 1,713,552 | 3.51M |
| 154 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | 0.05% | 6,291,490 | 1.00B |
| 155 | CHE | Chemed Corporation | 5.14B | 1.40% | 154,813 | 2.53B |
| 156 | TGTX | TG Therapeutics, Inc. | 5.07B | -0.87% | 1,823,586 | 616.29M |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 5.06B | -2.99% | 606,532 | 2.04M |
| 158 | WAY | Waystar Holding Corp. | 4.85B | 2.59% | 3,749,881 | 1.10B |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.68B | 0.14% | 901,899 | 761.41M |
| 160 | RDNT | RadNet, Inc. | 4.66B | 3.21% | 2,249,998 | 2.04B |
| 161 | OSCR | Oscar Health, Inc. | 4.65B | 0.26% | 3,799,499 | 11.70B |
| 162 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.07% | 3,004,700 | 634.21M |
| 163 | SHC | Sotera Health Company | 4.51B | -1.25% | 2,710,831 | 1.16B |
| 164 | DOCS | Doximity, Inc. | 4.48B | 1.46% | 3,792,203 | 637.78M |
| 165 | LGND | Ligand Pharmaceuticals Incorporated | 4.45B | -0.82% | 192,228 | 268.09M |
| 166 | OPCH | Option Care Health, Inc. | 4.45B | -0.04% | 1,815,553 | 5.65B |
| 167 | NVST | Envista Holdings Corporation | 4.39B | -0.33% | 1,576,778 | 2.72B |
| 168 | ALHC | Alignment Healthcare, Inc. | 4.25B | -0.48% | 1,849,116 | 3.95B |
| 169 | MMSI | Merit Medical Systems, Inc. | 4.18B | -0.89% | 486,840 | 1.52B |
| 170 | AMRX | Amneal Pharmaceuticals, Inc. | 4.18B | 0.31% | 1,306,872 | 3.02B |
| 171 | VKTX | Viking Therapeutics, Inc. | 4.12B | 0.17% | 1,512,449 | - |
| 172 | STVN | Stevanato Group S.p.A. | 4.10B | 1.97% | 679,556 | 1.39B |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.09B | -1.89% | 747,580 | 7.70M |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.96B | -1.45% | 375,424 | 747.14M |
| 175 | MMED | MiniMed Group, Inc. | 3.94B | -7.88% | 1,671,094 | 2.89B |
| 176 | LEGN | Legend Biotech Corporation | 3.90B | 2.73% | 3,666,835 | 1.03B |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.82B | -2.38% | 798,368 | 22.50M |
| 178 | GPCR | Structure Therapeutics Inc. | 3.79B | -1.38% | 548,122 | - |
| 179 | TMDX | TransMedics Group, Inc. | 3.77B | -6.02% | 1,006,721 | 605.49M |
| 180 | TVTX | Travere Therapeutics, Inc. | 3.65B | -3.44% | 4,562,074 | 490.73M |
| 181 | LQDA | Liquidia Corporation | 3.65B | 3.19% | 1,184,454 | 158.32M |
| 182 | BLLN | BillionToOne, Inc. | 3.62B | -2.22% | 298,834 | 305.11M |
| 183 | ACAD | ACADIA Pharmaceuticals Inc. | 3.62B | -2.34% | 1,677,626 | 1.07B |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.57B | -1.14% | 2,428,489 | 62.38M |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.56B | 0.75% | 304,404 | 803.79M |
| 186 | LIVN | LivaNova PLC | 3.56B | -0.20% | 559,584 | 1.39B |
| 187 | EWTX | Edgewise Therapeutics, Inc. | 3.55B | -1.72% | 497,904 | - |
| 188 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.47B | -1.24% | 623,200 | 677.56M |
| 189 | TWST | Twist Bioscience Corporation | 3.45B | -2.41% | 1,426,923 | 391.56M |
| 190 | HNGE | Hinge Health, Inc. | 3.38B | 3.50% | 783,271 | 587.86M |
| 191 | BKD | Brookdale Senior Living Inc. | 3.36B | 0.43% | 2,902,032 | 3.05B |
| 192 | ORKA | Oruka Therapeutics, Inc. | 3.32B | 2.32% | 1,315,755 | - |
| 193 | DYN | Dyne Therapeutics, Inc. | 3.29B | -0.35% | 1,920,449 | - |
| 194 | DNLI | Denali Therapeutics Inc. | 3.28B | -4.47% | 1,515,701 | - |
| 195 | TXG | 10x Genomics, Inc. | 3.22B | -0.43% | 1,798,915 | 642.82M |
| 196 | ALMS | Alumis Inc. | 3.18B | 3.48% | 1,557,056 | 24.05M |
| 197 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.16B | 0.15% | 913,079 | 588.99M |
| 198 | ICUI | ICU Medical, Inc. | 3.15B | -0.13% | 373,096 | 2.23B |
| 199 | VERA | Vera Therapeutics, Inc. | 3.03B | -2.78% | 931,671 | - |
| 200 | BEAM | Beam Therapeutics Inc. | 3.01B | -1.14% | 1,713,136 | 139.74M |
| 201 | ITGR | Integer Holdings Corporation | 3.01B | 0.49% | 258,357 | 1.85B |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | -1.59% | 900,783 | 376.07M |
| 203 | RCUS | Arcus Biosciences, Inc. | 2.96B | -0.46% | 678,451 | 247.00M |
| 204 | PRVA | Privia Health Group, Inc. | 2.95B | 0.26% | 665,116 | 2.12B |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 2.88B | -5.68% | 723,333 | 451.36M |
| 206 | RLAY | Relay Therapeutics, Inc. | 2.88B | 4.00% | 3,264,824 | 15.36M |
| 207 | CON | Concentra Group Holdings Parent, Inc. | 2.87B | -0.49% | 366,656 | 2.16B |
| 208 | IDYA | IDEAYA Biosciences, Inc. | 2.85B | 1.03% | 1,248,346 | 218.71M |
| 209 | WRBY | Warby Parker Inc. | 2.84B | -2.07% | 1,633,148 | 871.91M |
| 210 | SUPN | Supernus Pharmaceuticals, Inc. | 2.83B | -1.44% | 494,499 | 718.95M |
| 211 | HAE | Haemonetics Corporation | 2.79B | -2.97% | 837,616 | 1.32B |
| 212 | MANE | Veradermics, Incorporated | 2.77B | -7.93% | 519,461 | - |
| 213 | SLNO | Soleno Therapeutics, Inc. | 2.72B | - | 4,154,614 | 190.41M |
| 214 | ELVN | Enliven Therapeutics, Inc. | 2.71B | 3.16% | 1,488,106 | - |
| 215 | PBH | Prestige Consumer Healthcare Inc. | 2.70B | -0.90% | 363,639 | 1.10B |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.66B | -0.03% | 853,187 | 1.55M |
| 217 | IRON | Disc Medicine, Inc. | 2.65B | -1.04% | 260,079 | - |
| 218 | ZLAB | Zai Lab Limited | 2.65B | 1.08% | 1,340,925 | 460.16M |
| 219 | IMNM | Immunome, Inc. | 2.63B | -0.56% | 784,219 | 6.94M |
| 220 | VCYT | Veracyte, Inc. | 2.62B | -2.97% | 588,206 | 517.15M |
| 221 | LFST | LifeStance Health Group, Inc. | 2.60B | 1.83% | 1,358,990 | 1.42B |
| 222 | HCM | HUTCHMED (China) Limited | 2.56B | 0.39% | 18,152 | 548.51M |
| 223 | ADMA | ADMA Biologics, Inc. | 2.56B | 0.85% | 4,570,041 | 510.17M |
| 224 | HTFL | HeartFlow, Inc. | 2.56B | 1.95% | 1,070,002 | 176.03M |
| 225 | LMAT | LeMaitre Vascular, Inc. | 2.54B | -2.75% | 216,973 | 249.60M |
| 226 | MLYS | Mineralys Therapeutics, Inc. | 2.52B | 0.46% | 1,379,935 | - |
| 227 | NHC | National HealthCare Corporation | 2.52B | 1.33% | 104,913 | 1.52B |
| 228 | KOD | Kodiak Sciences Inc. | 2.49B | -3.74% | 980,006 | - |
| 229 | AAPG | Ascentage Pharma Group International | 2.48B | 0.26% | 540 | 82.08M |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.47B | 1.05% | 2,619,662 | 3.31B |
| 231 | OGN | Organon & Co. | 2.43B | 1.30% | 10,268,261 | 6.22B |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.41B | 0.33% | 2,555,812 | 3.68B |
| 233 | NKTR | Nektar Therapeutics | 2.41B | 0.93% | 668,628 | 55.23M |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.41B | -2.62% | 1,812,338 | 673.00M |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.39B | 0.85% | 4,319,862 | 874.84M |
| 236 | GRDN | Guardian Pharmacy Services, Inc. | 2.34B | -0.38% | 256,970 | 1.45B |
| 237 | DFTX | Definium Therapeutics, Inc. | 2.24B | 1.40% | 2,464,712 | - |
| 238 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | -2.58% | 2,572,242 | 2.20B |
| 239 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.09% | 1,220,026 | 158.18M |
| 240 | PAHC | Phibro Animal Health Corporation | 2.18B | -2.05% | 281,231 | 1.46B |
| 241 | BHC | Bausch Health Companies Inc. | 2.17B | 1.39% | 840,099 | 10.27B |
| 242 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | -3.10% | 1,303,071 | 276.98M |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -1.37% | 846,206 | 283.06M |
| 244 | SNDX | Syndax Pharmaceuticals, Inc. | 2.10B | -2.14% | 825,013 | 172.35M |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.09B | -0.56% | 326,762 | 184.42M |
| 246 | MESO | Mesoblast Limited | 2.08B | 2.16% | 229,513 | 65.38M |
| 247 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 1.36% | 832,208 | 54.03M |
| 248 | SION | Sionna Therapeutics, Inc. | 2.04B | 0.33% | 817,609 | - |
| 249 | SEM | Select Medical Holdings Corporation | 2.03B | 0.06% | 2,387,958 | 5.45B |
| 250 | GRAL | GRAIL, Inc. | 2.03B | -0.64% | 520,752 | 147.17M |
| 251 | NEOG | Neogen Corporation | 2.01B | -1.91% | 1,871,522 | 870.56M |
| 252 | ZYME | Zymeworks Inc. | 2.01B | -1.91% | 335,961 | 105.97M |
| 253 | CAPR | Capricor Therapeutics, Inc. | 1.99B | -1.28% | 849,319 | 11.13M |
| 254 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.96B | 3.56% | 2,377,548 | -665.00K |
| 255 | AXGN | Axogen, Inc. | 1.94B | 7.51% | 2,644,116 | 225.21M |
| 256 | OCUL | Ocular Therapeutix, Inc. | 1.93B | -0.56% | 2,018,405 | 51.95M |
| 257 | ANAB | AnaptysBio, Inc. | 1.92B | -1.46% | 1,297,753 | 234.60M |
| 258 | WGS | GeneDx Holdings Corp. | 1.92B | -3.02% | 366,410 | 427.54M |
| 259 | RXRX | Recursion Pharmaceuticals, Inc. | 1.90B | -4.00% | 16,375,626 | 74.68M |
| 260 | GLPG | Galapagos NV | 1.90B | -1.03% | 120,947 | 1.31B |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.90B | -3.15% | 857,203 | 211.08M |
| 262 | TYRA | Tyra Biosciences, Inc. | 1.89B | 0.43% | 1,804,885 | - |
| 263 | RAPP | Rapport Therapeutics, Inc. | 1.89B | 7.71% | 372,640 | - |
| 264 | PHVS | Pharvaris N.V. | 1.88B | -1.24% | 116,916 | - |
| 265 | TRVI | Trevi Therapeutics, Inc. | 1.87B | 1.89% | 1,022,691 | - |
| 266 | AHG | Akso Health Group | 1.82B | -3.62% | 177,265 | 14.84M |
| 267 | MD | Pediatrix Medical Group, Inc. | 1.80B | 0.09% | 361,704 | 1.91B |
| 268 | AORT | Artivion, Inc. | 1.78B | -1.95% | 265,245 | 441.33M |
| 269 | PVLA | Palvella Therapeutics, Inc. | 1.78B | -3.46% | 268,734 | - |
| 270 | ANIP | ANI Pharmaceuticals, Inc. | 1.78B | 2.08% | 263,325 | 883.37M |
| 271 | INVA | Innoviva, Inc. | 1.75B | -1.34% | 768,307 | 411.33M |
| 272 | NRIX | Nurix Therapeutics, Inc. | 1.73B | -1.65% | 888,165 | 71.78M |
| 273 | SGRY | Surgery Partners, Inc. | 1.72B | 1.59% | 699,570 | 3.31B |
| 274 | VCEL | Vericel Corporation | 1.72B | -4.52% | 380,762 | 276.26M |
| 275 | OMCL | Omnicell, Inc. | 1.71B | 0.19% | 348,206 | 1.18B |
| 276 | AHCO | AdaptHealth Corp. | 1.71B | -0.55% | 1,451,250 | 3.24B |
| 277 | TSHA | Taysha Gene Therapies, Inc. | 1.71B | -0.83% | 4,405,038 | 9.77M |
| 278 | HRMY | Harmony Biosciences Holdings, Inc. | 1.70B | 0.68% | 505,085 | 868.45M |
| 279 | ADUS | Addus HomeCare Corporation | 1.69B | 0.01% | 178,059 | 1.42B |
| 280 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -5.22% | 3,609,671 | 67.67M |
| 281 | NUVB | Nuvation Bio Inc. | 1.67B | -0.21% | 4,548,538 | 62.90M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.65B | 1.17% | 549,887 | 336.39M |
| 283 | VIR | Vir Biotechnology, Inc. | 1.65B | -1.24% | 1,253,178 | 68.56M |
| 284 | ATEC | Alphatec Holdings, Inc. | 1.64B | -5.25% | 1,923,998 | 764.16M |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.63B | 1.47% | 483,227 | - |
| 286 | INSP | Inspire Medical Systems, Inc. | 1.63B | -0.34% | 799,799 | 911.98M |
| 287 | OCS | Oculis Holding AG | 1.62B | -0.62% | 206,542 | 1.51M |
| 288 | GENB | Generate Biomedicines, Inc. | 1.61B | 0.88% | 291,397 | 31.89M |
| 289 | IMCR | Immunocore Holdings plc | 1.59B | -0.82% | 269,629 | 400.02M |
| 290 | NBTX | Nanobiotix S.A. | 1.59B | -2.23% | 52,070 | 38.27M |
| 291 | MBX | MBX Biosciences, Inc. | 1.58B | 0.79% | 217,048 | - |
| 292 | PRGO | Perrigo Company plc | 1.57B | 0.09% | 1,536,606 | 4.25B |
| 293 | BCAX | Bicara Therapeutics Inc. | 1.57B | 0.89% | 387,361 | - |
| 294 | IOVA | Iovance Biotherapeutics, Inc. | 1.57B | -0.52% | 11,014,677 | 263.50M |
| 295 | ARDX | Ardelyx, Inc. | 1.54B | -0.32% | 1,668,879 | 407.32M |
| 296 | ASTH | Astrana Health, Inc. | 1.51B | 4.69% | 582,366 | 3.18B |
| 297 | HROW | Harrow, Inc. | 1.51B | 4.80% | 761,087 | 272.30M |
| 298 | BHVN | Biohaven Ltd. | 1.51B | -3.47% | 1,600,034 | - |
| 299 | VRDN | Viridian Therapeutics, Inc. | 1.50B | -1.48% | 1,612,202 | 70.85M |
| 300 | UFPT | UFP Technologies, Inc. | 1.50B | -1.11% | 194,773 | 602.80M |
| 301 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | 2.58% | 1,104,570 | 123.67M |
| 302 | ATAI | AtaiBeckley Inc. | 1.49B | 2.25% | 16,706,330 | 4.09M |
| 303 | ATRC | AtriCure, Inc. | 1.46B | -1.67% | 462,491 | 534.53M |
| 304 | AVAH | Aveanna Healthcare Holdings Inc. | 1.46B | -0.15% | 1,419,453 | 2.43B |
| 305 | IMTX | Immatics N.V. | 1.46B | -1.18% | 160,844 | 56.67M |
| 306 | ENOV | Enovis Corporation | 1.45B | -0.51% | 757,154 | 2.25B |
| 307 | OLMA | Olema Pharmaceuticals, Inc. | 1.44B | -0.06% | 625,031 | - |
| 308 | NVCR | NovoCure Limited | 1.44B | 3.70% | 1,603,196 | 655.35M |
| 309 | SVRA | Savara Inc. | 1.43B | -3.92% | 1,196,980 | - |
| 310 | NVAX | Novavax, Inc. | 1.41B | -0.58% | 2,005,999 | 1.12B |
| 311 | PGNY | Progyny, Inc. | 1.40B | 3.11% | 1,301,826 | 1.29B |
| 312 | PGEN | Precigen, Inc. | 1.40B | 1.28% | 2,355,674 | 9.68M |
| 313 | PLSE | Pulse Biosciences, Inc. | 1.39B | 4.38% | 293,490 | 350.00K |
| 314 | PRCT | PROCEPT BioRobotics Corporation | 1.38B | -4.48% | 925,288 | 308.05M |
| 315 | WVE | Wave Life Sciences Ltd. | 1.38B | -3.56% | 3,003,378 | 42.73M |
| 316 | TNDM | Tandem Diabetes Care, Inc. | 1.38B | -2.76% | 1,188,309 | 1.01B |
| 317 | ARDT | Ardent Health, Inc. | 1.35B | - | 288,630 | 6.32B |
| 318 | BFLY | Butterfly Network, Inc. | 1.35B | 8.85% | 14,239,428 | 97.61M |
| 319 | MAZE | Maze Therapeutics, Inc. | 1.34B | 0.07% | 421,795 | 2.50M |
| 320 | HCSG | Healthcare Services Group, Inc. | 1.32B | -2.80% | 435,753 | 1.84B |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.31B | 0.68% | 380,011 | - |
| 322 | ZBIO | Zenas BioPharma, Inc. | 1.29B | 3.37% | 313,830 | 10.00M |
| 323 | MLTX | MoonLake Immunotherapeutics | 1.28B | -1.28% | 860,529 | - |
| 324 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | -0.46% | 632,464 | - |
| 325 | MPLT | MapLight Therapeutics, Inc. | 1.26B | 5.99% | 203,164 | - |
| 326 | PHAR | Pharming Group N.V. | 1.24B | -2.64% | 7,695 | 376.13M |
| 327 | EYPT | EyePoint, Inc. | 1.24B | 1.23% | 588,192 | 31.37M |
| 328 | DBVT | DBV Technologies S.A. | 1.23B | -3.01% | 77,535 | 5.64M |
| 329 | NNNN | Anbio Biotechnology | 1.22B | 1.09% | 27,025 | 8.65M |
| 330 | STAA | STAAR Surgical Company | 1.22B | -0.44% | 1,079,982 | 239.44M |
| 331 | INBX | Inhibrx Biosciences, Inc. | 1.21B | -0.59% | 120,680 | 1.30M |
| 332 | KMTS | Kestra Medical Technologies, Ltd. | 1.19B | 1.09% | 228,451 | 83.72M |
| 333 | USPH | U.S. Physical Therapy, Inc. | 1.18B | 1.97% | 91,897 | 773.34M |
| 334 | CMPX | Compass Therapeutics, Inc. | 1.18B | 11.62% | 7,118,346 | 850.00K |
| 335 | IRMD | IRADIMED CORPORATION | 1.17B | -1.26% | 67,647 | 83.81M |
| 336 | EVO | Evotec SE | 1.17B | 0.31% | 54,607 | 925.65M |
| 337 | ABCL | AbCellera Biologics Inc. | 1.16B | -0.78% | 2,911,897 | 75.13M |
| 338 | IVA | Inventiva S.A. | 1.16B | -1.92% | 567,442 | 7.94M |
| 339 | CDNA | CareDx, Inc. | 1.15B | 27.60% | 2,964,544 | 379.81M |
| 340 | AVNS | Avanos Medical, Inc. | 1.15B | -0.24% | 3,853,119 | 701.20M |
| 341 | CNMD | CONMED Corporation | 1.14B | -3.88% | 471,081 | 1.37B |
| 342 | INNV | InnovAge Holding Corp. | 1.14B | 2.70% | 253,807 | 915.37M |
| 343 | CLOV | Clover Health Investments, Corp. | 1.13B | 0.47% | 4,969,707 | 1.92B |
| 344 | ALVO | Alvotech | 1.13B | -1.09% | 167,706 | 588.90M |
| 345 | SEPN | Septerna, Inc. | 1.12B | -3.63% | 352,207 | 45.95M |
| 346 | AZTA | Azenta, Inc. | 1.12B | -2.53% | 794,015 | 595.03M |
| 347 | GHRS | GH Research PLC | 1.10B | 4.35% | 212,300 | - |
| 348 | GERN | Geron Corporation | 1.08B | - | 8,451,346 | 183.88M |
| 349 | JBIO | Jade Biosciences, Inc. | 1.08B | 13.60% | 673,053 | - |
| 350 | COLL | Collegium Pharmaceutical, Inc. | 1.07B | -5.41% | 763,372 | 780.57M |
| 351 | PNTG | The Pennant Group, Inc. | 1.06B | -0.39% | 314,182 | 947.71M |
| 352 | NEO | NeoGenomics, Inc. | 1.06B | -5.99% | 1,719,370 | 727.33M |
| 353 | CTMX | CytomX Therapeutics, Inc. | 1.06B | 7.24% | 5,678,475 | 76.20M |
| 354 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | -1.29% | 1,435,533 | 291.85M |
| 355 | QURE | uniQure N.V. | 1.05B | -2.55% | 1,321,345 | 16.10M |
| 356 | TDOC | Teladoc Health, Inc. | 1.05B | 5.05% | 4,373,467 | 2.53B |
| 357 | URGN | UroGen Pharma Ltd. | 1.04B | -0.56% | 996,804 | 109.79M |
| 358 | AKTS | Aktis Oncology, Inc. | 1.03B | 2.82% | 356,115 | 6.50M |
| 359 | ORIC | ORIC Pharmaceuticals, Inc. | 1.03B | -0.49% | 1,363,015 | - |
| 360 | CRON | Cronos Group Inc. | 1.02B | -1.47% | 1,197,036 | 146.59M |
| 361 | ANNX | Annexon, Inc. | 1.02B | -0.31% | 2,413,689 | - |
| 362 | BLFS | BioLife Solutions, Inc. | 1.01B | -1.60% | 347,350 | 96.21M |
| 363 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | -6.23% | 2,265,817 | 73.62M |
| 364 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | -1.41% | 810,760 | 175.11M |
| 365 | AMPH | Amphastar Pharmaceuticals, Inc. | 989.52M | 0.60% | 361,313 | 719.89M |
| 366 | SSII | SS Innovations International, Inc. | 985.70M | 0.61% | 44,888 | 42.48M |
| 367 | PCRX | Pacira BioSciences, Inc. | 966.09M | 1.84% | 423,590 | 726.41M |
| 368 | EVMN | Evommune, Inc. | 964.21M | -0.63% | 277,579 | 13.00M |
| 369 | CERT | Certara, Inc. | 944.48M | 0.16% | 4,242,568 | 418.84M |
| 370 | FTRE | Fortrea Holdings Inc. | 943.42M | 0.40% | 1,524,479 | 2.72B |
| 371 | SANA | Sana Biotechnology, Inc. | 926.03M | 0.87% | 2,058,563 | - |
| 372 | JANX | Janux Therapeutics, Inc. | 924.03M | 1.00% | 623,732 | 10.00M |
| 373 | OPK | OPKO Health, Inc. | 918.47M | 2.54% | 4,433,902 | 606.88M |
| 374 | ABUS | Arbutus Biopharma Corporation | 914.84M | 4.46% | 2,225,178 | 14.08M |
| 375 | ANRO | Alto Neuroscience, Inc. | 913.47M | 2.32% | 321,352 | - |
| 376 | XNCR | Xencor, Inc. | 913.07M | -0.48% | 635,515 | 125.58M |
| 377 | INMD | InMode Ltd. | 907.93M | 0.56% | 1,186,476 | 370.50M |
| 378 | OMER | Omeros Corporation | 902.83M | 2.37% | 1,092,175 | - |
| 379 | CGEM | Cullinan Therapeutics, Inc. | 892.16M | -1.40% | 420,777 | - |
| 380 | SDGR | Schrödinger, Inc. | 890.33M | -2.74% | 2,795,269 | 255.87M |
| 381 | SLS | SELLAS Life Sciences Group, Inc. | 885.34M | 0.41% | 3,415,146 | - |
| 382 | MRVI | Maravai LifeSciences Holdings, Inc. | 876.60M | -2.57% | 2,090,971 | 185.74M |
| 383 | LMRI | Lumexa Imaging Holdings, Inc. | 870.28M | -4.98% | 1,731,119 | 1.02B |
| 384 | BVS | Bioventus Inc. | 865.64M | -1.42% | 740,083 | 568.09M |
| 385 | TBPH | Theravance Biopharma, Inc. | 864.05M | 0.84% | 526,793 | 107.46M |
| 386 | TALK | Talkspace, Inc. | 863.78M | - | 1,646,202 | 228.87M |
| 387 | QDEL | QuidelOrtho Corporation | 863.62M | -27.47% | 14,130,297 | 2.73B |
| 388 | CMPS | COMPASS Pathways plc | 858.63M | 11.74% | 9,757,421 | - |
| 389 | DRUG | Bright Minds Biosciences Inc. | 851.14M | -1.08% | 198,153 | - |
| 390 | MNKD | MannKind Corporation | 849.19M | -0.72% | 3,025,613 | 348.97M |
| 391 | IART | Integra LifeSciences Holdings Corporation | 844.84M | -1.72% | 928,591 | 1.64B |
| 392 | SGP | SpyGlass Pharma, Inc. | 836.67M | 1.21% | 22,070 | - |
| 393 | SLDB | Solid Biosciences Inc. | 825.53M | 0.84% | 672,656 | - |
| 394 | SPRY | ARS Pharmaceuticals, Inc. | 812.25M | 2.00% | 1,292,774 | 84.28M |
| 395 | VOR | Vor Biopharma Inc. | 811.16M | -4.04% | 724,989 | - |
| 396 | GDRX | GoodRx Holdings, Inc. | 805.05M | 1.29% | 1,574,796 | 796.85M |
| 397 | KURA | Kura Oncology, Inc. | 793.54M | -1.22% | 1,045,784 | 67.48M |
| 398 | AMN | AMN Healthcare Services, Inc. | 790.52M | 5.58% | 780,380 | 2.73B |
| 399 | TLRY | Tilray Brands, Inc. | 789.18M | -2.30% | 2,719,325 | 858.28M |
| 400 | OMDA | Omada Health, Inc. | 787.83M | 1.91% | 936,215 | 260.21M |
| 401 | ALLO | Allogene Therapeutics, Inc. | 785.13M | 9.22% | 28,838,769 | 22.00K |
| 402 | CBLL | CeriBell, Inc. | 780.68M | 1.02% | 191,238 | 89.06M |
| 403 | LXRX | Lexicon Pharmaceuticals, Inc. | 779.57M | -1.08% | 1,969,267 | 49.80M |
| 404 | MGTX | MeiraGTx Holdings plc | 772.11M | -15.73% | 4,424,316 | 81.39M |
| 405 | DSGN | Design Therapeutics, Inc. | 771.52M | -1.88% | 563,851 | - |
| 406 | FBRX | Forte Biosciences, Inc. | 769.35M | 0.48% | 201,826 | - |
| 407 | BIOA | BioAge Labs, Inc. | 754.01M | 0.12% | 367,252 | 9.00M |
| 408 | CSTL | Castle Biosciences, Inc. | 744.07M | -0.24% | 261,814 | 344.23M |
| 409 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 737.90M | -1.81% | 244,479 | - |
| 410 | RLMD | Relmada Therapeutics, Inc. | 734.22M | -2.51% | 1,855,175 | - |
| 411 | GYRE | Gyre Therapeutics, Inc. | 721.38M | -1.50% | 35,328 | 116.59M |
| 412 | LBRX | LB Pharmaceuticals Inc | 715.46M | -2.88% | 711,834 | - |
| 413 | NUTX | Nutex Health Inc. | 709.10M | -6.64% | 466,574 | 875.26M |
| 414 | IRWD | Ironwood Pharmaceuticals, Inc. | 706.04M | -0.92% | 1,853,564 | 296.15M |
| 415 | ARVN | Arvinas, Inc. | 703.57M | 0.27% | 980,860 | 262.60M |
| 416 | DRTS | Alpha Tau Medical Ltd. | 701.44M | 1.14% | 492,293 | - |
| 417 | PSNL | Personalis, Inc. | 697.15M | 0.45% | 879,816 | 69.65M |
| 418 | EHAB | Enhabit, Inc. | 696.43M | 0.15% | 1,315,095 | 1.06B |
| 419 | TENX | Tenax Therapeutics, Inc. | 678.05M | -3.78% | 534,865 | - |
| 420 | ETON | Eton Pharmaceuticals, Inc. | 666.56M | -9.42% | 762,775 | 79.95M |
| 421 | OCGN | Ocugen, Inc. | 652.14M | -1.03% | 4,805,963 | 4.41M |
| 422 | PRME | Prime Medicine, Inc. | 649.88M | -3.17% | 1,519,384 | 4.63M |
| 423 | CBIO | Crescent Biopharma, Inc. | 646.01M | -2.51% | 74,109 | 10.84M |
| 424 | HSTM | HealthStream, Inc. | 627.05M | 1.52% | 172,853 | 304.06M |
| 425 | BWAY | BrainsWay Ltd. | 624.52M | -3.04% | 156,653 | 52.23M |
| 426 | ZVRA | Zevra Therapeutics, Inc. | 610.60M | 0.78% | 809,646 | 106.47M |
| 427 | EIKN | Eikon Therapeutics, Inc. | 608.52M | 3.69% | 159,949 | - |
| 428 | SIBN | SI-BONE, Inc. | 603.74M | -5.66% | 548,670 | 200.93M |
| 429 | CTKB | Cytek Biosciences, Inc. | 592.62M | -1.71% | 477,211 | 201.49M |
| 430 | AVR | Anteris Technologies Global Corp. | 592.42M | -5.25% | 993,001 | 1.91M |
| 431 | PROK | ProKidney Corp. | 588.74M | -2.99% | 842,647 | 893.00K |
| 432 | RIGL | Rigel Pharmaceuticals, Inc. | 586.89M | -0.90% | 413,863 | 294.28M |
| 433 | KYTX | Kyverna Therapeutics, Inc. | 576.14M | 1.38% | 467,448 | - |
| 434 | TCMD | Tactile Systems Technology, Inc. | 571.72M | -0.87% | 168,404 | 329.52M |
| 435 | PRTA | Prothena Corporation plc | 566.32M | -2.77% | 298,913 | 9.68M |
| 436 | CRMD | CorMedix Inc. | 563.63M | -1.38% | 868,599 | 311.71M |
| 437 | EMBC | Embecta Corp. | 563.18M | -1.04% | 570,033 | 1.08B |
| 438 | TECX | Tectonic Therapeutic, Inc. | 557.29M | -0.03% | 127,401 | - |
| 439 | PHR | Phreesia, Inc. | 557.20M | 1.21% | 1,601,393 | 480.59M |
| 440 | VSTM | Verastem, Inc. | 556.92M | 0.16% | 2,653,194 | 30.91M |
| 441 | ADCT | ADC Therapeutics SA | 556.45M | 0.23% | 2,206,370 | 81.36M |
| 442 | STTK | Shattuck Labs, Inc. | 555.53M | 2.51% | 286,086 | 1.00M |
| 443 | ACRS | Aclaris Therapeutics, Inc. | 553.20M | 1.27% | 1,108,422 | 7.83M |
| 444 | LYEL | Lyell Immunopharma, Inc. | 552.88M | -0.59% | 57,762 | 36.00K |
| 445 | UPB | Upstream Bio, Inc. | 549.64M | 2.23% | 1,152,806 | 2.85M |
| 446 | ANL | Adlai Nortye Ltd. | 547.60M | 3.32% | 938,624 | 5.00M |
| 447 | AGMB | AgomAb Therapeutics NV | 545.85M | 5.07% | 521,650 | - |
| 448 | BBNX | Beta Bionics, Inc. | 542.76M | -6.45% | 1,601,490 | 100.25M |
| 449 | ZURA | Zura Bio Limited | 541.77M | 0.35% | 691,205 | - |
| 450 | ENGN | enGene Therapeutics Inc. | 541.27M | 4.12% | 285,474 | - |
| 451 | FULC | Fulcrum Therapeutics, Inc. | 532.14M | -3.15% | 997,598 | 80.00M |
| 452 | IMMX | Immix Biopharma, Inc. | 528.00M | -0.80% | 743,765 | - |
| 453 | ESPR | Esperion Therapeutics, Inc. | 526.46M | -5.53% | 7,925,386 | 403.14M |
| 454 | VALN | Valneva SE | 521.75M | -1.00% | 27,126 | 205.07M |
| 455 | NPCE | NeuroPace, Inc. | 521.16M | -0.83% | 83,613 | 99.99M |
| 456 | AQST | Aquestive Therapeutics, Inc. | 519.91M | 0.47% | 961,402 | 44.55M |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 513.58M | 2.97% | 837,067 | 85.21M |
| 458 | AGL | agilon health, inc. | 513.44M | 15.10% | 372,057 | 5.93B |
| 459 | MDXG | MiMedx Group, Inc. | 509.58M | -11.60% | 3,672,327 | 418.63M |
| 460 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 461 | OFIX | Orthofix Medical Inc. | 497.39M | -3.73% | 286,006 | 822.31M |
| 462 | CTNM | Contineum Therapeutics, Inc. | 496.57M | 0.38% | 653,785 | - |
| 463 | ABSI | Absci Corporation | 494.26M | 1.89% | 3,230,238 | 2.80M |
| 464 | PACB | Pacific Biosciences of California, Inc. | 492.26M | 1.87% | 5,346,943 | 160.01M |
| 465 | LRMR | Larimar Therapeutics, Inc. | 490.33M | -2.28% | 1,186,952 | - |
| 466 | TRDA | Entrada Therapeutics, Inc. | 488.16M | -3.07% | 154,576 | 25.42M |
| 467 | LXEO | Lexeo Therapeutics, Inc. | 487.49M | -3.24% | 479,116 | - |
| 468 | VREX | Varex Imaging Corporation | 486.27M | -1.53% | 166,771 | 854.40M |
| 469 | STRO | Sutro Biopharma, Inc. | 486.25M | -1.41% | 195,063 | 102.48M |
| 470 | CATX | Perspective Therapeutics, Inc. | 485.36M | -2.74% | 907,594 | 884.00K |
| 471 | IVVD | Invivyd, Inc. | 483.59M | - | 1,264,673 | 53.43M |
| 472 | KMDA | Kamada Ltd. | 480.17M | -2.37% | 33,229 | 180.46M |
| 473 | RGNX | REGENXBIO Inc. | 474.36M | -1.82% | 365,730 | 170.44M |
| 474 | XOMA | XOMA Royalty Corporation | 471.98M | -1.30% | 106,328 | 52.15M |
| 475 | MYGN | Myriad Genetics, Inc. | 467.54M | -3.66% | 1,359,616 | 824.50M |
| 476 | FLGT | Fulgent Genetics, Inc. | 465.26M | -0.25% | 425,690 | 322.67M |
| 477 | ASMB | Assembly Biosciences, Inc. | 465.09M | -1.64% | 175,050 | 72.30M |
| 478 | DNA | Ginkgo Bioworks Holdings, Inc. | 462.75M | 2.05% | 1,471,422 | 170.16M |
| 479 | BNTC | Benitec Biopharma Inc. | 461.07M | -1.03% | 122,118 | - |
| 480 | ALT | Altimmune, Inc. | 456.67M | 3.24% | 2,580,476 | 41.00K |
| 481 | VTVT | vTv Therapeutics Inc. | 456.05M | -2.57% | 32,434 | 17.00K |
| 482 | AVIR | Atea Pharmaceuticals, Inc. | 454.13M | -3.06% | 246,633 | - |
| 483 | AURA | Aura Biosciences, Inc. | 452.90M | -0.42% | 285,749 | - |
| 484 | EBS | Emergent BioSolutions Inc. | 445.18M | -0.46% | 537,081 | 742.90M |
| 485 | EPRX | Eupraxia Pharmaceuticals Inc. | 440.89M | -2.70% | 184,860 | - |
| 486 | CGC | Canopy Growth Corporation | 438.79M | - | 8,080,841 | 203.04M |
| 487 | IPSC | Century Therapeutics, Inc. | 438.52M | -5.79% | 1,220,117 | 109.16M |
| 488 | ANGO | AngioDynamics, Inc. | 435.99M | 1.16% | 389,304 | 313.73M |
| 489 | PRTC | PureTech Health plc | 433.38M | -0.16% | 3,677 | 6.39M |
| 490 | AUTL | Autolus Therapeutics plc | 428.49M | 8.05% | 1,607,148 | 75.39M |
| 491 | RCKT | Rocket Pharmaceuticals, Inc. | 425.58M | 0.52% | 2,474,863 | - |
| 492 | VNDA | Vanda Pharmaceuticals Inc. | 423.21M | -1.51% | 861,957 | 216.11M |
| 493 | CLYM | Climb Bio, Inc. | 421.32M | 1.97% | 378,177 | - |
| 494 | WEAV | Weave Communications, Inc. | 419.98M | 2.30% | 883,216 | 239.02M |
| 495 | CYH | Community Health Systems, Inc. | 419.00M | -0.63% | 724,760 | 12.49B |
| 496 | KIDS | OrthoPediatrics Corp. | 417.86M | -7.39% | 172,209 | 236.35M |
| 497 | ARMP | Armata Pharmaceuticals, Inc. | 416.88M | -5.64% | 36,204 | 4.90M |
| 498 | IRD | Opus Genetics, Inc. | 409.11M | 0.70% | 437,054 | 14.20M |
| 499 | AUNA | Auna S.A. | 408.55M | 2.22% | 370,245 | 1.30B |
| 500 | LCTX | Lineage Cell Therapeutics, Inc. | 408.50M | 0.61% | 866,170 | 14.56M |